a partner in the German Center for Diabetes Research (DZD), together with US colleagues in the renowned "Diabetes Prevention Program (DPP)," have now been able to show for the first time that people ...
Real-world studies on GLP-1s like Ozempic show lower weight loss than clinical trials, with high discontinuation rates due to adverse effects, costs, and unmet expectations, raising concerns about ...